AC Immune SA (ACIU) Form 10-K Annual Reports
AC Immune SA (ACIU) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ACIU
CIK: 1651625
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V8
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers AG
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerAlex Fuhrer
Audit LocationLausanne, Switzerland
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3/A | 2026-10-09 | 2026-10-02 | FORM 3/A | 0000950103-26-015456 | View SEC Doc Filr Page |
| 3 | 2026-10-09 | 2026-10-02 | PRIMARY DOCUMENT | 0001651625-26-000024 | View SEC Doc Filr Page |
| 6-K | 2026-10-02 | 2026-10-02 | 6-K | 0001651625-26-000023 | View SEC Doc Filr Page |
| 6-K | 2026-09-23 | 2026-09-23 | 6-K | 0001651625-26-000020 | View SEC Doc Filr Page |
| 6-K | 2026-09-03 | 2026-09-03 | FORM 6-K | 0000950103-26-013536 | View SEC Doc Filr Page |
| 6-K | 2026-08-20 | 2026-08-20 | 6-K | 0001651625-26-000018 | View SEC Doc Filr Page |
| 6-K | 2026-08-11 | 2026-08-11 | 6-K | 0001651625-26-000016 | View SEC Doc Filr Page |
| 6-K | 2026-08-05 | 2026-06-30 | 6-K | 0001104659-26-090704 | View SEC Doc Filr Page |
| 6-K | 2026-06-30 | 2026-06-30 | FORM 6-K | 0000950103-26-009745 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | PRIMARY DOCUMENT | 0001651625-26-000012 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | PRIMARY DOCUMENT | 0001651625-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | PRIMARY DOCUMENT | 0001651625-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | PRIMARY DOCUMENT | 0001651625-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | PRIMARY DOCUMENT | 0001651625-26-000008 | View SEC Doc Filr Page |
| 6-K | 2026-06-11 | 2026-06-11 | FORM 6-K | 0000950103-26-008857 | View SEC Doc Filr Page |
| 6-K | 2026-06-11 | 2026-06-11 | FORM 6-K | 0000950103-26-008815 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-15 | PRIMARY DOCUMENT | 0001651625-26-000007 | View SEC Doc Filr Page |
| 144 | 2026-05-15 | — | 144 Filing | 0001950047-26-004616 | View SEC Doc Filr Page |
| 6-K | 2026-05-15 | 2026-05-15 | FORM 6-K | 0000950103-26-007252 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-05-12 | FORM 6-K | 0000950103-26-007082 | View SEC Doc Filr Page |
| 6-K | 2026-04-30 | 2026-04-30 | FORM 6-K | 0000950103-26-006499 | View SEC Doc Filr Page |
| 6-K | 2026-04-30 | 2026-04-30 | FORM 6-K | 0000950103-26-006498 | View SEC Doc Filr Page |
| 4/A | 2026-04-16 | 2026-04-15 | PRIMARY DOCUMENT | 0001651625-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-15 | PRIMARY DOCUMENT | 0001651625-26-000005 | View SEC Doc Filr Page |
| 144 | 2026-04-15 | — | 144 Filing | 0001950047-26-003516 | View SEC Doc Filr Page |